MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 66 filers reported holding MERSANA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $181,000 | -20.6% | 9,756 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $228,000 | +612.5% | 9,756 | +77.2% | 0.02% | +650.0% |
| Q1 2020 | $32,000 | +300.0% | 5,507 | +295.1% | 0.00% | – |
| Q4 2019 | $8,000 | +166.7% | 1,394 | -30.3% | 0.00% | – |
| Q3 2019 | $3,000 | +200.0% | 2,001 | +519.5% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 323 | +12.2% | 0.00% | – |
| Q1 2019 | $2,000 | – | 288 | +1209.1% | 0.00% | – |
| Q4 2017 | $0 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |